Scarica l'app Stockscreener
49.75
0.48%
-0.24
Dopo l'orario di chiusura:
49.48
-0.27
-0.54%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CYTK Giù?
Forum
Previsione
Frazionamento azionario
Cytokinetics Inc Borsa (CYTK) Ultime notizie
Using Python tools to backtest Cytokinetics Incorporated strategies2025 Retail Activity & Safe Capital Growth Tips - Newser
Cytokinetics (CYTK) Rockets 40.45% as Aficamten Results Promising - MSN
Cytokinetics Incorporated stock prediction for this week2025 Risk Factors & Long-Term Growth Portfolio Plans - Newser
Cytokinetics Gains on Positive Late-Stage Cardiomyopathy Study Results - Zacks Investment Research
Is Cytokinetics Incorporated stock bottoming outMarket Performance Summary & Long-Term Capital Growth Strategies - Newser
Will Cytokinetics Incorporated benefit from rate cutsInsider Selling & Risk Controlled Stock Alerts - khodrobank.com
Understanding Cytokinetics Incorporated’s price movement2025 Biggest Moves & Community Trade Idea Sharing Platform - Newser
Does Cytokinetics Incorporated show high probability of reboundJuly 2025 PostEarnings & Long Hold Capital Preservation Tips - Newser
Predicting Cytokinetics Incorporated trend using moving averagesGDP Growth & Safe Entry Trade Reports - Newser
Can Cytokinetics Incorporated recover in the next quarterMarket Rally & Free Safe Capital Growth Stock Tips - Newser
Applying chart zones and confluence areas to Cytokinetics Incorporated2025 Year in Review & Growth Oriented Trade Recommendations - Newser
What’s next for Cytokinetics Incorporated stock pricePortfolio Profit Report & Long-Term Growth Plans - Newser
Technical signs of recovery in Cytokinetics IncorporatedMarket Sentiment Summary & Safe Entry Zone Tips - Newser
Detecting support and resistance levels for Cytokinetics IncorporatedChart Signals & High Win Rate Trade Alerts - Newser
How high can Cytokinetics Incorporated stock goJuly 2025 Macro Moves & Long-Term Growth Stock Strategies - Newser
Real time social sentiment graph for Cytokinetics IncorporatedTrade Risk Report & Low Drawdown Trading Techniques - Newser
Cytokinetics’ Aficamten with breakthrough Phase III results - European Biotechnology Magazine
Cytokinetics Shares Jump 40.45% on Aficamten HCM Data $630M Volume Ranks 162nd - AInvest
Is Cytokinetics Incorporated on track to beat earnings2025 Key Highlights & Smart Swing Trading Techniques - khodrobank.com
Should I buy Cytokinetics Incorporated stock nowIPO Watch & Daily Profit Maximizing Trade Tips - khodrobank.com
Cytokinetics’ Aficamten Shows Head-To-Head Advantage Vs. Beta Blockers - insights.citeline.com
How to read the order book for Cytokinetics IncorporatedEarnings Recap Report & Weekly Top Gainers Alerts - Newser
Nvidia, PepsiCo, Tesla, Kraft Heinz, Constellation Brands, Cytokinetics, and More Market Movers - Barron's
Cytokinetics at Citi’s Biopharma Conference: Aficamten’s Promising Path - Investing.com
Cytokinetics Skyrockets On 'Provocative' Results In Heart Disease - Investor's Business Daily
Aficamten Bests Metoprolol in Cytokinetics' Trial for Obstructive Hypertrophic Cardiomyopathy - PharmTech
Bitcoin gains, Frontier upgraded, Cytokinetics trial results - Yahoo Finance
Cytokinetics: Game-Changing Data Confirms Best-In-Class Potential (NASDAQ:CYTK) - Seeking Alpha
Cytokinetics says heart disease drug more effective than standard-of-care, shares jump - TradingView
Cytokinetics’ Aficamten: Navigating Regulatory Hurdles and Market Potential in the OHCM Space - AInvest
Cytokinetics Appoints New Director Amid Revenue Boost and Strategic Moves - StocksToTrade
Board Appointment Boosts Cytokinetics’ Growth Projections - timothysykes.com
Cytokinetics Shares are Jumping. Its Heart Drug Looks Better than Ever - Barron's
Cytokinetics (CYTK) Stock Is Skyrocketing Tuesday: What's Driving The Action? - Benzinga
Cytokinetics makes its case for heart-failure drug ahead of FDA decision, stock surges more than 40% - The Business Journals
Cytokinetics shares surge 35.66% in premarket after positive results from MAPLE-HCM III trial. - AInvest
Cytokinetics Soars 35.13% on Promising Heart Disease Data - AInvest
Is Cytokinetics Incorporated’s ROE strong enough2025 Major Catalysts & Advanced Swing Trade Entry Plans - khodrobank.com
Fed Watch: Is Cytokinetics Incorporated a top pick in the sectorCEO Change & Safe Investment Capital Preservation Plans - خودرو بانک
Retail Buzz Soars As Cytokinetics Jumps 34% In Europe On Heart Drug Breakthrough - Stocktwits
Is Cytokinetics Incorporated forming a reversal patternJuly 2025 Review & Safe Capital Investment Plans - Newser
Pattern recognition hints at Cytokinetics Incorporated upside2025 Top Gainers & Free Weekly Watchlist of Top Performers - Newser
Multi asset correlation models including Cytokinetics IncorporatedQuarterly Trade Summary & Step-by-Step Trade Execution Guides - Newser
Risk adjusted return profile for Cytokinetics Incorporated analyzedMarket Growth Summary & Technical Pattern Based Signals - Newser
Published on: 2025-09-01 20:47:13 - khodrobank.com
Cytokinetics Incorporated stock retracement – recovery analysis2025 Investor Takeaways & Daily Stock Trend Watchlist - Newser
Will Cytokinetics Incorporated benefit from macro trendsMarket Rally & Risk Managed Investment Strategies - Newser
Custom Dashboard Highlights Cytokinetics Incorporated Price MomentumJuly 2025 Spike Watch & Low Drawdown Investment Strategies - beatles.ru
Cytokinetics’ aficamten bests beta blocker in head-to-head trial - The Pharma Letter
Cytokinetics Incorporated stock volume spike explainedQuarterly Trade Summary & Weekly Sector Rotation Insights - Newser
What the charts say about Cytokinetics Incorporated todayWeekly Trade Summary & Community Consensus Trade Signals - Newser
How to build a custom watchlist for Cytokinetics IncorporatedMarket Activity Summary & Daily Technical Stock Forecast Reports - Newser
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):